US 6756038
Agonist and antagonist peptides of carcinoembryonic antigen (CEA)
expired A61KA61K38/00A61K39/00
Quick answer
US patent 6756038 (Agonist and antagonist peptides of carcinoembryonic antigen (CEA)) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jun 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Jun 29 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 24 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K38/00, A61K39/00, A61K48/00, A61P